Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Tablets/Capsules
| Brand name | TRAZODONE HYDROCHLORIDE |
| Generic name | TRAZODONE HYDROCHLORIDE |
| Active ingredient(s) | TRAZODONE HYDROCHLORIDE |
| Distributed by / for | Teva Pharmaceuticals, Parsippany, NJ 07054 |
| NDC | 50111-560-01 |
| Full product label | traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01 |
| Recalling firm | Teva Pharmaceuticals USA, Inc |
| Distribution | U.S. Nationwide |
| Quantity | 175,392 bottles |
| Recall initiated | 2026-08-24 |
| Report date | 2026-09-09 |
| Recall completed | — |
| Recall number | D-0834-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗